In-house roundup: Poll shows UPC attractive without UK; generics support European SPC system; antibody case law better in US than Europe

Email a friend Your name:

Your email:

Please enter a maximum of 5 recipients. Use ; to separate more than one email address.

Recipient email(s):

Recipient name(s):

Email yourself a copy?

05 September 2019 |

Patrick Wingrove, London

Managing IP rounds up the latest news and analysis from patent-focused businesses

Money

Survey: UPC still attractive without UK

In a Patent Strategy poll of more than 50 in-house counsel, 78% of respondents said a harmonised European patent system would still be useful if a post-Brexit UK were unable to participate. Read more...

Poll: SPC system wanted by most generics

In part two of Patent Strategy’s survey, almost all in-house respondents backed a European SPC system, but were less unified on the SPC Regulation’s reliability for new technologies or third-party MAs. Read more...

Antibody case law clearer in the US than Europe

Pharma innovators say clearer standards on how monoclonal antibody patent applications are reviewed at the USPTO and US national courts have made it easier to file patents there than at the EPO. Read more...

Comments

Display this name

Notify me of follow up comments

I have read and agree to the terms & conditions.

{{article|snippet:'title'|removeHtmlTags}}

{{article|fields:'dates'|date:dateArticleFormat}} | {{article|fields:'authors'}}

In-house roundup: Poll shows UPC attractive without UK; generics support European SPC system; antibody case law better in US than Europe

Survey: UPC still attractive without UK

Poll: SPC system wanted by most generics

Antibody case law clearer in the US than Europe

Comments

Related Articles

Most read articles

In-house intrigue over UK AI-inventor guidelines

In-house roundup: No war over autonomous vehicle standards; what the patent quality hearing didn't cover

The 50 most influential people in IP

AIPLA 2019: Trade secrets key to autonomous car IP strategies

IP STARS 2020 research and webinar

Latest Country Updates

IP STARS 2020 research and webinar

EPO: Appeal Board vetoes EPC regulation

Germany: Court blocks prior art time travel

Turkey: Is a public interest compulsory licence on the way?

Russia: Chamber of Patent Disputes cancels design on second attempt

Canada: Two different approaches to patent applications

Patent Q&A sponsored by Wanhuida – Peksung

IP High Court gives new ruling on patent term extension

How to deal with IP enforcement challenges in Indonesia

Belgium - The (too) effective Belgian descriptive seizures

Supplements

Americas IP Focus 2019

Asia-Pacific 2019 IP Focus

Japanese Buyers’ Guide 2019

Future of IP – Artificial Intelligence 2019

Turkey IP Focus 2019

About Managing IP

My Managing IP

Resources

Site Policies

In-house roundup: Poll shows UPC attractive without UK; generics support European SPC system; antibody case law better in US than Europe

Comments

Related Articles

Most read articles

Latest Country Updates

Supplements

Welcome to Managing Intellectual Property